On August 30, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and have a digital company presentation at the following investor conferences (Press release, Herantis Pharma, AUG 30, 2021, View Source,c3405763 [SID1234586989]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pareto Securities’ 12th Annual Healthcare Conference 2021 – September 1-2, 2021

Virtual Presentation: September 1, 2021 at 11:30 – 12:00 EEST / 10:30 – 11:00 CEST

Redeye Investor Forum – September 2, 2021

Virtual Presentation at 17:20 – 17:40 EEST / 16:20 – 16:40 CEST

Swiss Biotech Day – September 7, 2021

1×1 meetings

MedInvest Central Nervous System Investor Conference – September 8-9, 2021

Virtual Presentation: September 9, 2021 at 17:00 – 17:30 EEST / 16:00 – 16:30 CEST

H.C. Wainwright 23rd Annual Global Investment Conference – September 13-15, 2021

Virtual Presentation: September 13, 2021 at 14:00 – 14:30 EEST / 13:00 – 13:30 CEST

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the organizers at the Pareto Securities, Redeye, H.C. Wainwright, MedInvest, and Swiss Biotech if you wish to attend and/or schedule a meeting with Herantis.

On August 30, 2021 OPKO Health, Inc. (NASDAQ: OPK) reported that management will be participating in two upcoming virtual investor conferences (Press release, Opko Health, AUG 30, 2021, View Source [SID1234587004]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

14th Annual Barrington Research Fall Conference, September 9, 2021. Management will be available for one-on-one and small-group virtual meetings with investors during the event.

H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021. Management will participate in a fireside chat and will be available for one-on-one virtual meetings with investors. The recorded fireside chat will be available on demand beginning Monday, September 13th on the Investors section of OPKO Health’s website.

On August 30, 2021 I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, reported its participation in the following conferences in September (Press release, I-Mab Biopharma, AUG 30, 2021, View Source [SID1234587021]). Details of the conferences and management presentations are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Asia Forum (Virtual)

One-on-one and small group meetings: September 9, 2021

Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations

For more information, please contact your Jefferies representative.

H. C. Wainwright 23rd Annual Global Investment Conference (Virtual)

Presentation: Monday, September 13, 2021 at 7:00 a.m. ET
Presenter: Mr. Jielun Zhu, Director and Chief Financial Officer

Webcast link: View Source The webcast will also be available under "Event Calendar" on IMAB’s IR website at View Source

One-on-one and small group meetings: September 13-15, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations

For more information, please contact your H. C. Wainwright representative.

ICA China Biotech Corporate Access Day (Virtual)

One-on-one and small group meetings: September 23, 2021

Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations

For more information, please contact your ICA representative.

2021 Cantor Fitzgerald Global Healthcare Conference (Virtual)

Presentation: Monday, September 27, 2021 at 8:40 a.m. ET
Presenter: Mr. Jielun Zhu, Director and Chief Financial Officer

Webcast link: View Source The webcast will also be available under "Event Calendar" on IMAB’s IR website at View Source

One-on-one meetings: September 27-30, 2021
Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. Tianyi Zhang, Executive Director Investor Relations, Mr. Tyler Ehler, Senior Director Investor Relations and Phoebe Peng, Associate Director Investor Relations

For more information, please contact your Cantor Fitzgerald representative.

On August 30, 2021 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) ("Innate" or the "Company") reported that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences (Press release, Innate Pharma, AUG 30, 2021, View Source [SID1234586990]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

September 07, 2021 – Goldman Sachs 11th Annual Biotech Symposium

September 08-09, 2021 – Citi 16th Annual Biopharma Virtual Conference

September 13, 2021 – H.C.Wainwright 23rd Annual Global Investment Conference

On August 30, 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, reported that it is scheduled to speak at the Morgan Stanley 19th Annual Global Healthcare Conference (Press release, Quest Diagnostics, AUG 30, 2021, View Source [SID1234587005]). Steve Rusckowski, Chairman, CEO and President and Jim Davis, Executive Vice President, General Diagnostics will discuss the company’s vision, goals and two-point strategy to accelerate growth and drive operational excellence, as well as the company’s current perspective on the impact of the COVID-19 pandemic. The presentation is scheduled for Thursday, September 9, 2021, at 9:30 a.m. Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast live during the conference and will be available on the company’s investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 9, 2021.